Tuesday , July 23 2019
Home | U.S. | US approves the first female viagra

US approves the first female viagra

The Drug Agency reported on Tuesday that they have approved the first pill designed to treat decreasing libido in women. The Viagra for women will be produced by the American laboratory Sprout Pharmaceuticals under the name Addyi and is specifically designed to treat hypoactive sexual desire disorder (HSDD), a decrease of sexual desire in premenopausal women.

Despite its comparison with the famous blue pill, which acts to help men achieve an erection or treat certain deficiencies of testosterone, the “pink Viagra” is focused on increasing sexual desire, something that didn’t exist in the farmaceutical market until now. The main difference with the Viagra for men is that it should be taken for a period of time and not only just before having sex.

http://youthindependent.com/wp-content/uploads/it_aint_bad_to_love_like_this_by_jbigz.jpg

Another difference with the male version is that Addyi will be accompanied by medical warnings about using it with alcohol due to the possible side effects, which range from hypotension to a loss of consciousness. Doctors who prescribe it (you can buy freely in pharmacies) should receive specific training. They will have to ensure that the patient knows and understands the risks about this medicine, and you will need to fill in a form certifying that you have been informed about all the risks.

“Patients should fully understand the risks associated with the use of Addyi before considering this treatment,” said the center’s director of research and evaluation of the FDA, Janet Woodcock.

The approval by the FDA of female Viagra was somewhat expected. A group of experts approved it in June.

However, the announcement was hailed as a milestone, especially by pressure groups who had accused the federal agency of requiring more drug tests on women than on men. Among those who greeted the announcement of the FDA highlighted this point.

The president of an umbrella organization that demands equal treatment for sexual dysfunction problems of women, Susan Scanlan, tweeted that the news is a “step forward for women.”

The director of the Consumers’ Association (National Consumers League), Sally Greenberg, said the FDA’s decision is “the greatest advance in the sexual health of women since the pill,” The New York Times reports.
Not all have been applause. Some groups accuse the FDA of giving in to pressure. They opposed the approval of a drug with a lot of potentially dangerous side effects.

“This is nothing but a mixture of politics, science and money,” said the psychologist and sex therapist Leonore Tiefer, advocating that the FDA reject the drug. “This is not a drug that you take an hour before having sex. You have to take it for weeks or even months before you even see some benefit.”

Without making specific reference to criticism from both sides, Woodcock said to the FDA “we fight to protect the health of women.” The government agency “is committed to support the development of female sexual dysfunction effective and safe treatments.”

 

About Miguel Flores

Miguel Flores
In love with cinema, wine and poetry. I combine my work as luggage porter with the writing of narrative essays and journalistic articles .